Cleared Traditional

K941168 - CLINICAL ASSAYS GAMMACOAT [125] ESTRADI...

K941168 is the FDA 510(k) clearance for CLINICAL ASSAYS GAMMACOAT [125] ESTRADI... by Incstar Corp.. It is a Class 1 Chemistry device (product code CHP) cleared through the Traditional 510(k) pathway after a 177-day FDA review.

K941168 · Incstar Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1994
Decision
177d
Days
Class 1
Risk

K941168 is an FDA 510(k) clearance for the CLINICAL ASSAYS GAMMACOAT [125] ESTRADIOL RADIOIMMUNOASSAY KIT. Classified as Radioimmunoassay, Estradiol (product code CHP), Class I - General Controls.

Submitted by Incstar Corp. (Stillwater, US). The FDA issued a Cleared decision on September 7, 1994 after a review of 177 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1260 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Incstar Corp. devices

Submission Details

510(k) Number K941168 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 14, 1994
Decision Date September 07, 1994
Days to Decision 177 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
89d slower than avg
Panel avg: 88d · This submission: 177d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CHP Radioimmunoassay, Estradiol
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1260
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CHP Radioimmunoassay, Estradiol

All 31
Devices cleared under the same product code (CHP) and FDA review panel - the closest regulatory comparables to K941168.
ESTRADIOL ASSAY FOR THE TECHNICON IMMUNO 1 SYSTEM IN-VITRO DIAGNOSTIC SYSTEM
K951360 · Bayer Corp. · May 1995
AURAFLEX(R) ESTRADIOL
K946199 · Organon Teknika Corp. · Apr 1995
COAT-A-COUNT(R) ESTRADIOL-6
K943193 · Diagnostic Products Corp. · Feb 1995
IMMULITE ESTRADIOL
K932926 · Diagnostic Products Corp. · Jan 1994
CIBA CORNING ACS ESTRADIOL IMMUNOASSAY
K932715 · Ciba Corning Diagnostics Corp. · Dec 1993
AIA-PACK E2 ASSAY
K932084 · Tosoh Medics, Inc. · Nov 1993